Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AgfiledCriticalBayer Schering Pharma Ag
Priority to UY30434ApriorityCriticalpatent/UY30434A1/en
Publication of UY30434A1publicationCriticalpatent/UY30434A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un derivado de quinazolina que responde a la formula general (A): en la cual R1, R2, X, Y y Z tienen los valores que se indican en la memoria desciptiva y sus reivindicaciones, uso de los compuestos de la formula general (A) para el tratamiento de diversos trastornos, y preparacion de compuestos de la formula general (A).A quinazoline derivative that responds to the general formula (A): in which R1, R2, X, Y and Z have the values indicated in the specification and their claims, use of the compounds of the general formula (A ) for the treatment of various disorders, and preparation of compounds of the general formula (A).
UY30434A2007-06-222007-06-22
DERIVATIVES OF QUINAZOLINE, ITS PREPARATION, ITS USE AND DRUGS THAT UNDERSTAND THEM
UY30434A1
(en)
SUBSTITUTED DERIVATIVES OF N4- (5-METHYL-1H-PIRAZOL-3-IL) - 1,3,5-TRIAZINA-2,4-DIAMINE, THEIR ENANTIOMERS, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS, PREPARATION PROCESSES AND APPLICATIONS
DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE TREATMENT OF CHRONIC VENOUS DISEASES.